|Bid||155.15 x 1000|
|Ask||155.70 x 800|
|Day's Range||152.49 - 157.50|
|52 Week Range||33.72 - 189.26|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||174.25|
Stéphane Bancel, Moderna CEO, joins Yahoo Finance to discuss efficacy of the Moderna vaccine and the development of vaccine boosts.
Dr. Howard Forman, Yale School of Public Health Professor joins the Yahoo Finance Live panel to discuss the latest with the JNJ vaccine.
The growing concerns about a rare blood-clotting disorder that has been reported in people who received the vaccines developed by AstraZeneca PLC and Oxford University and Johnson & Johnson dominated COVID-19 news on Wednesday, with Denmark becoming the first country to fully discontinue use of the AstraZeneca jab.